SCR-LIP-000728 · Claim · machine-readable JSON →
A polymorphism in the interleukin-six gene may be associated with increased lipedema risk.
General proposition consolidated from 1 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 2 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (1)
- The role of IL-6 gene polymorphisms in the risk of lipedema — Di Renzo L et al. (2020) ✓ verified — consistent · cross sectional · 2020 · reading confidence: moderate
Carriers of the IL-6 rs1800795 G allele had higher lipedema risk (OR 5.92, 95% CI 1.98-17.71, p<0.001).
The article proposes composite body-composition indices and IL-6 genotyping as promising tools for diagnosis and differential analysis of lipedema, indirectly supporting that screening/diagnostic tools can help identify it; however it does
Context (PECO)
Answers these questions
- What specific genetic variants or inheritance patterns have been identified in lipedema? consistent
- Can screening tools or questionnaires help identify lipedema cases? contextual
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000025